Insulin Resistance and the Brain

Insulin is a hormone that facilitates glucose uptake into cells and plays complex regulatory roles throughout the body. In the brain, insulin receptors are concentrated in the hippocampus and cerebral cortex — regions critical for memory and executive function. Brain insulin signaling modulates synaptic plasticity, supports neuronal survival, regulates amyloid processing, and influences tau phosphorylation.

Insulin resistance — a state in which cells become less responsive to insulin's signals — impairs these functions in the brain. The brain typically synthesizes some of its own insulin (central insulin signaling is partially independent of peripheral insulin), but peripheral insulin resistance and hyperinsulinemia do affect brain insulin function through blood-brain barrier transport and downstream signaling effects.

The informal designation of Alzheimer's disease as 'Type 3 diabetes' — proposed by researcher Suzanne de la Monte and colleagues — reflects observations that Alzheimer's brains show impaired insulin signaling, reduced insulin receptor expression, and resistance to insulin's neurotrophic effects. While 'Type 3 diabetes' is not an official clinical designation, it captures the mechanistic overlap between metabolic dysfunction and Alzheimer's pathology.

Type 2 diabetes increases the risk of Alzheimer's disease by approximately 50-65% and is associated with accelerated cognitive aging even in people who do not develop dementia. The mechanisms are multiple: chronic hyperglycemia damages cerebral vasculature, insulin resistance impairs amyloid and tau processing, and the systemic inflammation associated with metabolic syndrome promotes neuroinflammation.

Even in people without diagnosed diabetes, insulin resistance (as measured by fasting insulin, HbA1c, or glucose tolerance testing) is associated with greater amyloid accumulation and faster cognitive decline in longitudinal studies. Metabolic health in midlife appears to be an important determinant of cognitive trajectory in late life.

The good news is that insulin resistance is highly modifiable. Regular aerobic exercise is among the most potent insulin-sensitizing interventions available. Dietary approaches that reduce glycemic load — particularly reducing ultra-processed carbohydrates and added sugars — improve insulin sensitivity. Weight loss in people with obesity substantially improves metabolic health and appears to improve cognitive performance measures.